GET THE APP

Formulation of an Optimised Glimepiride Compression Coated Tablets for Chronotherapeutic Drug Delivery | Abstract

Asian Journal of Pharmaceutical Technology and Innovation (ajpti)

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Formulation of an Optimised Glimepiride Compression Coated Tablets for Chronotherapeutic Drug Delivery

Abstract

Airemwen C.O*, Uhumwangho M.U and Obakpolor S.O

Background: Chronopharmaceutics is an aspect of pharmaceutics devoted to the formulation of drug delivery systems that release their active ingredients at a rhythm that ideally matches the physiological requirement of a particular disease condition. Objective: The aim of the present study is to formulate an optimized coated glimepiride time release tablets (CGTRT) containing glimepiride, a third generation sulphonylurea in the inner core for chronotherapeutic drug delivery system. Method: Glimepiride core tablets (GCT) containing Anacardium occidentale gum (10 %w/w) as binder and maize starch as disintegrant (10 %w/w) were prepared at compression pressure of 30 unit on the arbitrary load scale. CGTRT containing Anacardium occidentale gum powder with sodium starch glycolate at varying concentration (0.5%, 1%, 2%, 4%, and 6%w/w) were also prepared at 30 unit on the arbitrary load scale. The parameters determined were hardness, friability, drug content, disintegration time and in vitro drug release profile. Result: The hardness value of the core tablet and market formulation was > 4.1 Kpa while their friability values were 1.7% (core) and 1.2% (market formulation). The core tablet and market formulation disintegrated in 7min and 6min respectively, while their drug content was > 97%. The hardness and friability values of the CGTRT were > 12 KPa and < 0.59% respectively. All CGTRT displayed different lag time and this was dependent on the concentration of the sodium starch glycolate incorporated into the CGTRT. The drug content of the formulations was > 94%. Conclusion: CGTRT1 with a lag time of 6 h before release of glimepiride was taken as the optimized formulation..

Share this article